Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
3-Year Return on Invested Incremental Capital (3-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 3-year.
Chongqing Xishan Science and Technology Co's 3-Year ROIIC % for the quarter that ended in Dec. 2025 was -3.44%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
SHSE:688576's 3-Year ROIIC % is ranked worse than 56.23% of 795
companies
in the Medical Devices & Instruments industry
Industry Median: 1.47
vs SHSE:688576: -3.44
Chongqing Xishan Science and Technology Co (SHSE:688576) 3-Year ROIIC % Explanation
Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.
High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.
Be Aware
It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.
Chongqing Xishan Science and Technology Co 3-Year ROIIC % Related Terms
Chongqing Xishan Science and Technology Co 3-Year ROIIC % Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Chongqing Xishan Science and Technology Co 3-Year ROIIC % Chart
Chongqing Xishan Science and Technology Co Annual Data
SHSE:688576 vs ISRG, BDX, MDLN: 3-Year ROIIC % Comparison
For the Medical Instruments & Supplies subindustry, Chongqing Xishan Science and Technology Co's 3-Year ROIIC %, along with its competitors' market caps and 3-Year ROIIC % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Chongqing Xishan Science and Technology Co 3-Year ROIIC % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Chongqing Xishan Science and Technology Co's 3-Year ROIIC % distribution charts can be found below:
* The bar in red indicates where Chongqing Xishan Science and Technology Co's 3-Year ROIIC % falls into.
3-Year Incremental Net Operating Profit After Taxes (NOPAT)**
/
3-Year Incremental Invested Capital**
=
( 39.4327184 (Dec. 2025) - 70.123 (Dec. 2022) )
/
( 1025.433 (Dec. 2025) - 134.464 (Dec. 2022) )
=
-30.6902816
/
890.969
=
-3.44%***
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
** Annual data of NOPAT and Invested Capital was used to calculate 3-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.
Chongqing Xishan Science and Technology Co (SHSE:688576) has a 3-Year ROIIC % of -3.44 as of Dec. 2025. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Chongqing Xishan Science and Technology Co and its competitors. According to the industry distribution chart, Chongqing Xishan Science and Technology Co ranks #447 out of 795 companies in the Medical Devices & Instruments industry, placing it in the top 56.2%.
Is Chongqing Xishan Science and Technology Co's 3-Year ROIIC % too high?
Chongqing Xishan Science and Technology Co's current 3-Year ROIIC % is -3.44. Based on the distribution chart, Chongqing Xishan Science and Technology Co ranks #447 out of 795 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Chongqing Xishan Science and Technology Co has a GF Score™ of 92/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Chongqing Xishan Science and Technology Co's 3-Year ROIIC % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Chongqing Xishan Science and Technology Co ranks #447 out of 795 companies for 3-Year ROIIC %. This places Chongqing Xishan Science and Technology Co in the lower half of its industry. The industry median 3-Year ROIIC % is 1.47. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year ROIIC % for a Medical Devices & Instruments company?
The median 3-Year ROIIC % among Medical Devices & Instruments companies is 1.47, based on 795 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year ROIIC % significantly above this median, while those in the bottom quartile fall well below. However, 3-Year ROIIC % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year ROIIC % mean?
A high 3-Year ROIIC % can signal that a stock is expensive relative to its fundamentals. 3-Year ROIIC % measures the change in earnings as a percentage of change in investment over 3-year. View historical data on Chongqing Xishan Science and Technology Co and its competitors. For the Medical Devices & Instruments industry, the median 3-Year ROIIC % is 1.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Chongqing Xishan Science and Technology Co's current 3-Year ROIIC % is -3.44. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Chongqing Xishan Science and Technology Co stock overvalued right now?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co (SHSE:688576) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥54.05, compared to a current price of ¥41.79 — trading 22.7% below its estimated fair value. The current 3-Year ROIIC % is -3.44. Chongqing Xishan Science and Technology Co's overall GF Score™ is 92/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year ROIIC % calculated?
3-Year ROIIC % is calculated from a company's financial statements. For Chongqing Xishan Science and Technology Co (SHSE:688576), the current 3-Year ROIIC % is -3.44 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Chongqing Xishan Science and Technology Co (SHSE:688576) Overvalued in 2026?
Based on GuruFocus' analysis, Chongqing Xishan Science and Technology Co stock appears to be undervalued.
The current stock price of ¥41.79 is trading 22.7% below its estimated GF Value™ of ¥54.05.
GuruFocus considers Chongqing Xishan Science and Technology Co to be Modestly Undervalued.
Key valuation signals for SHSE:688576:
3-Year ROIIC %: -3.44
GF Value™: ¥54.05 vs. price of ¥41.79 (22.7% below fair value)
No single metric tells the full story. See the SHSE:688576 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressNo. 9, Middle Section of Huangshan Avenue, Jupiter Science and Technology Development Center, High-tech Park, North New District, Chongqing, CHN, 401121
Chongqing Xishan Science and Technology Co Ltd focuses on surgical instruments, especially in the field of minimally invasive surgical instruments. It is mainly engaged in the research, development, production and sales of minimally invasive surgical instruments. Speculum, energy surgery equipment and other products, currently the products are mainly used in neurosurgery, ENT, orthopedics, breast surgery and other clinical departments. The company's main products are surgical power units, consumables and accessories, which are mainly used for cutting, grinding, planing, sawing, milling and trimming of bone tissue and soft tissue in surgical operations, especially minimally invasive surgical operations.
92GF Score
Get the complete analysis for SHSE:688576
3-Year ROIIC % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
SHSE:688576 has been successfully added to your 
